IMPACT Therapeutics

IMPACT Therapeutics is a China based Company

Britain to send Nanjing Pharmaceutical Co., Ltd. (hereinafter referred to as the British faction Pharmaceutical) was incorporated in June 2009, dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more than four decades of experience in drug development and management. General Manager and Chief Scientific Officer Field is an expert in pharmacology and biology.